Evidence map›Paper›PMID 35203313›Full record

ArticleCells2022

Comparative Analysis of Gene Expression in Fibroblastic Foci in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis.

Jan C Kamp, Lavinia Neubert, Helge Stark, Jan B Hinrichs, Caja Boekhoff, Allison D Seidel, Fabio Ius, Axel Haverich, Jens Gottlieb, Tobias Welte and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Overview of multi-omics approaches for pulmonary sarcoidosis.EC pulmonology and respiratory medicine · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Immune mechanisms in fibrotic pulmonary sarcoidosis.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  11. B4GALT1 as a New Biomarker of Idiopathic Pulmonary Fibrosis.International journal of molecular sciences · 2022
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Jan C KampDepartment of Respiratory Medicine, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0002-5002-409X
Lavinia NeubertBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), 30625 Hannover, Germany.
Helge StarkBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), 30625 Hannover, Germany.ORCID 0000-0002-2668-8056
Jan B HinrichsBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), 30625 Hannover, Germany.ORCID 0000-0002-0135-7082
Caja BoekhoffInstitute for Pathology, Hannover Medical School, 30625 Hannover, Germany.
Allison D SeidelInstitute for Pathology, Hannover Medical School, 30625 Hannover, Germany.
Fabio IusBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), 30625 Hannover, Germany.
Axel HaverichBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), 30625 Hannover, Germany.ORCID 0000-0002-0991-2650
Jens GottliebDepartment of Respiratory Medicine, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0002-9540-9022
Tobias WelteDepartment of Respiratory Medicine, Hannover Medical School, 30625 Hannover, Germany.
Peter BraubachBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), 30625 Hannover, Germany.ORCID 0000-0003-3673-7779
Florian LaengerBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), 30625 Hannover, Germany.
Marius M HoeperDepartment of Respiratory Medicine, Hannover Medical School, 30625 Hannover, Germany.
Mark P KuehnelBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), 30625 Hannover, Germany.
Danny D JonigkBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), 30625 Hannover, Germany.ORCID 0000-0002-5251-2281
Medizinische Hochschule Hannover · DE

Funding

Deutsche Forschungsgemeinschaft KFO311Deutsche Forschungsgemeinschaft PRACTIS - Clinician Scientist Program of Hannover Medical School, (DFG, ME 3696/3-1European Research Council European Consolidator Grant, XHaLe (ref. no. 771883)
6 · The paper itself

Abstract

backgroundFibroblastic foci (FF) are characteristic features of usual interstitial pneumonia (UIP)/idiopathic pulmonary fibrosis (IPF) and one cardinal feature thought to represent a key mechanism of pathogenesis. Hence, FF have a high impact on UIP/IPF diagnosis in current guidelines. However, although less frequent, these histomorphological hallmarks also occur in other fibrotic pulmonary diseases. Currently, there is therefore a gap in knowledge regarding the underlying molecular similarities and differences of FF in different disease entities.

methodsIn this work, we analyzed the compartment-specific gene expression profiles of FF in IPF and sarcoidosis in order to elucidate similarities and differences as well as shared pathomechanisms. For this purpose, we used laser capture microdissection, mRNA and protein expression analysis. Biological pathway analysis was performed using two different gene expression databases. As control samples, we used healthy lung tissue that was donated but not used for lung transplantation.

resultsBased on Holm Bonferroni corrected expression data, mRNA expression analysis revealed a significantly altered expression signature for 136 out of 760 genes compared to healthy controls while half of these showed a similar regulation in both groups. Immunostaining of selected markers from each group corroborated these results. However, when comparing all differentially expressed genes with the

conclusionsThese results demonstrate that FF of end-stage IPF and sarcoidosis lungs, although different in initiation, are similar in gene and protein expression, encouraging further studies on the use of antifibrotic agents in sarcoidosis.

Indexed as

Idiopathic Pulmonary FibrosisSarcoidosisSarcoidosis, PulmonaryHumansRNA, MessengerTranscriptomeUbiquitin-Protein LigasesRNA, MessengerSMURF1 protein, humanUbiquitin-Protein Ligasesfibroblastic fociidiopathic pulmonary fibrosislaser microdissectionsarcoidosis

Identifiers

PMID35203313
PMCPMC8870272
OpenAlexW4212986083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.